Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
73.67
+5.41 (7.93%)
At close: Apr 2, 2025, 4:00 PM
71.96
-1.71 (-2.31%)
After-hours: Apr 2, 2025, 7:49 PM EDT

Soleno Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-175.85-38.99-24.07-30.91-24.64
Upgrade
Depreciation & Amortization
1.991.961.961.961.95
Upgrade
Loss (Gain) From Sale of Investments
-4.9----
Upgrade
Stock-Based Compensation
99.965.952.533.281.5
Upgrade
Other Operating Activities
3.693.22-0.45-0.95-7.01
Upgrade
Change in Accounts Payable
5.671.37-1.48-0.241.49
Upgrade
Change in Other Net Operating Assets
0.351.560.72-0.911.48
Upgrade
Operating Cash Flow
-69.1-24.94-20.78-27.77-25.22
Upgrade
Capital Expenditures
-0.22--0.01-0.02-0.01
Upgrade
Investment in Securities
-225.46----
Upgrade
Investing Cash Flow
-225.68--0.01-0.02-0.01
Upgrade
Long-Term Debt Issued
49.89----
Upgrade
Total Debt Issued
49.89----
Upgrade
Long-Term Debt Repaid
----0.01-0.02
Upgrade
Total Debt Repaid
----0.01-0.02
Upgrade
Net Debt Issued (Repaid)
49.89---0.01-0.02
Upgrade
Issuance of Common Stock
163.14180.0214.11-53.74
Upgrade
Repurchase of Common Stock
---0.02-0.12-
Upgrade
Financing Cash Flow
213.03180.0214.09-0.1353.72
Upgrade
Net Cash Flow
-81.75155.08-6.7-27.9228.49
Upgrade
Free Cash Flow
-69.31-24.94-20.79-27.79-25.23
Upgrade
Free Cash Flow Per Share
-1.73-1.51-2.48-5.23-6.04
Upgrade
Levered Free Cash Flow
-7.47-12.82-11.71-15.79-13.3
Upgrade
Unlevered Free Cash Flow
-7.33-12.82-11.71-15.79-13.3
Upgrade
Change in Net Working Capital
-6.21-3.440.490.85-3.22
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q